NanoString Technologies (BMV:NSTG *) - Prezzo delle azioni, notizie e analisi

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

NSTG * Panoramica delle azioni

Develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific.

Informazioni sull'azienda

NSTG * analisi fondamentale
Punteggio fiocco di neve
Valutazione	4/6
Crescita futura	1/6
Prestazioni passate	0/6
Salute finanziaria	0/6
Dividendi	0/6

Premi

Trading at 89.1% below our estimate of its fair value

Revenue is forecast to grow 16.2% per year

Analisi del rischio

Negative shareholders equity

Shares are highly illiquid

Does not have a meaningful market cap (MX$38M)

Shareholders have been diluted in the past year

+ 2 più rischi

NS Wind Down Co., Inc. Concorrenti

DNA Chip Research

TSE:2397

JP¥5.0b

Cryosite

ASX:CTE

AU$43.0m

Magle Chemoswed Holding

OM:MAGLE

SEK 644.1m

Hyundai ADM Bio

KOSDAQ:A187660

₩78.7b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per NanoString Technologies
Prezzi storici delle azioni
Prezzo attuale dell'azione	US$29.32
Massimo di 52 settimane	US$233.89
Minimo di 52 settimane	US$29.32
Beta	1.32
1Variazione di 1 mese	0%
Variazione a 3 mesi	n/a
Variazione di 1 anno	n/a
3Variazione a 3 anni	n/a
Variazione a 5 anni	n/a
Variazione dall'IPO	-96.72%

Notizie e aggiornamenti recenti

Recent updates

Rendimenti per gli azionisti

	NSTG *	MX Life Sciences	MX Mercato
7D	0%	0%	0%
1Y	n/a	0%	0%

Ritorno vs Industria: Insufficient data to determine how NSTG * performed against the MX Life Sciences industry.

Rendimento vs Mercato: Insufficient data to determine how NSTG * performed against the MX Market.

Volatilità dei prezzi

Is NSTG *'s price volatile compared to industry and market?
NSTG * volatility
NSTG * Average Weekly Movement	n/a
Life Sciences Industry Average Movement	0%
Market Average Movement	0%
10% most volatile stocks in MX Market	0%
10% least volatile stocks in MX Market	0%

Prezzo delle azioni stabile: NSTG * has not had significant price volatility in the past 3 months.

Volatilità nel tempo: Insufficient data to determine NSTG *'s volatility change over the past year.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2003	550	Brad Gray	www.nanostring.com

NS Wind Down Co., Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di NanoString Technologies con la sua capitalizzazione di mercato?
NSTG * statistiche fondamentali
Capitalizzazione di mercato	Mex$652.58m
Guadagni(TTM)	-Mex$2.83b
Ricavi(TTM)	Mex$2.76b

0.2x

Rapporto P/S

-0.2x

Rapporto P/E

NSTG * è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
NSTG * Conto economico (TTM)
Ricavi	US$162.47m
Costo del fatturato	US$104.44m
Profitto lordo	US$58.04m
Altre spese	US$224.47m
Guadagni	-US$166.43m

Ultimi guadagni dichiarati

Sep 30, 2023

Prossima data di guadagno

n/a

Utile per azione (EPS)	-3.46
Margine lordo	35.72%
Margine di profitto netto	-102.44%
Rapporto debito/patrimonio netto	-450.4%

Come si è comportato NSTG * nel lungo periodo?

Vedi performance storica e confronto

This company listing is no longer active

NSTG * Panoramica delle azioni

Premi

Analisi del rischio

NS Wind Down Co., Inc. Concorrenti

TSE:2397

JP¥5.0b

ASX:CTE

AU$43.0m

OM:MAGLE

SEK 644.1m

KOSDAQ:A187660

₩78.7b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

NS Wind Down Co. Files Form 15

NS Wind Down Co., Inc. Emerged from Bankruptcy

First Amended Disclosure Statement Approved for NanoString Technologies, Inc.

NanoString Technologies, Inc. announced delayed 10-Q filing

Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.

Recent updates

NS Wind Down Co. Files Form 15

NS Wind Down Co., Inc. Emerged from Bankruptcy

First Amended Disclosure Statement Approved for NanoString Technologies, Inc.

NanoString Technologies, Inc. announced delayed 10-Q filing

Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.

The Nasdaq Stock Market to Delist the Common Stock of Nanostring Technologies

NanoString Technologies, Inc. announced delayed annual 10-K filing

Patient Square Capital, LP agreed to acquire Substantially all assets of global business operations from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $220 million.

NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from NASDAQ Composite Index

NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from S&P Global BMI Index

Motion for Joint Administration Approved for NanoString Technologies, Inc.

Motion for Joint Administration Filed by NanoString Technologies, Inc.

NanoString Technologies, Inc. Filed for Bankruptcy

Nanostring Launches the CosMx 6,000 Plex RNA Assay and Showcases Whole Transcriptome Imaging Capability

NanoString Technologies, Inc. Releases the First Public Dataset of the Whole Transcriptome Obtained At True Single-Cell Resolution on the CosMx Spatial Molecular Imager

NanoString Technologies Receives Non-Compliance Notice from Nasdaq

10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023

NanoString Technologies, Inc. to Report Q3, 2023 Results on Nov 06, 2023

NanoString Technologies, Inc. Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered

Nanostring Appoints Todd Garland as Chief Commercial Officer

New major risk - Negative shareholders equity

Second quarter 2023 earnings released: US$0.92 loss per share (vs US$0.84 loss in 2Q 2022)

NanoString Technologies, Inc. Reiterates Earnings Guidance for the Full Year 2023

Delaware District Court Permits NanoString Technologies, Inc.'s Counterclaims That 10x Genomics and Harvard Violated the Antitrust Laws

NanoString Technologies, Inc. to Report Q2, 2023 Results on Aug 03, 2023

10X Genomics, Inc. Files New Patent Litigation Against Nanostring Technologies, Inc. and Vizgen, Inc. in the European Unified Patent Court

10X Genomics Wins Permanent Injunction Against Nanostring's CosMX Products

NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023

Independent Director recently bought Mex$2.2m worth of stock

Full year 2022 earnings released: US$3.44 loss per share (vs US$2.54 loss in FY 2021)

NanoString Technologies, Inc. to Report Q4, 2022 Results on Feb 28, 2023

NanoString Technologies, Inc. Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology

NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager

NanoString Technologies, Inc. Provides Product and Service Revenue Guidance for the Fourth Quarter and Full Year 2022

CEO, President & Director recently bought Mex$9.8m worth of stock

NanoString Technologies, Inc Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform

Third quarter 2022 earnings released: US$0.79 loss per share (vs US$0.69 loss in 3Q 2021)

Now 21% undervalued after recent price drop

NanoString Technologies, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Now 30% undervalued

Now 20% undervalued

Now 21% undervalued after recent price drop

Now 20% undervalued

Nanostring Technologies, Inc. Provides Revenue Guidance for 2022

Second quarter 2022 earnings released: US$0.84 loss per share (vs US$0.60 loss in 2Q 2021)

NanoString Technologies, Inc. to Report Q2, 2022 Results on Aug 04, 2022

NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting

Nanostring Technologies, Inc. Announces Plans to Commercially Unveil the Cosmx™ Spatial Molecular Imager

NanoString Technologies, Inc. Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing

NanoString Technologies, Inc. Announces Resignation of Robert Hershberg from the Board

NanoString Technologies, Inc. Launches New nCounter Pro Analysis System

NanoString Technologies, Inc. Announces Release of a Fully Automated GeoMx RNA Protocol on BOND RX Research Staining Systems

NanoString Technologies, Inc. to Report Q4, 2021 Results on Mar 01, 2022

Nanostring Technologies, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2021

Rendimenti per gli azionisti

Volatilità dei prezzi

Informazioni sull'azienda

NS Wind Down Co., Inc. Riepilogo dei fondamenti